Skip to main content
. Author manuscript; available in PMC: 2014 Nov 21.
Published in final edited form as: Analyst. 2013 Nov 21;138(22):10.1039/c3an01076g. doi: 10.1039/c3an01076g

Fig. 5.

Fig. 5

Expression of surface receptors after exposure to no gradient, fMLP gradient, CXCL8 gradient, and a CXCL8-fMLP competing gradient (denoted as 8-fMLP). (a) FPR2 expression in untreated (green) and p38 MAPK-blocked (blue) neutrophils. (b) BLTR expression in untreated (green) and p38 MAPK-blocked (blue) neutrophils. (c) CXCR1 expression in untreated (green) and p38 MAPK-blocked neutrophils.